A citation-based method for searching scientific literature

Nick S R Lan, Bu B Yeap, P Gerry Fegan, Gillian Green, James M Rankin, Girish Dwivedi. Int J Cardiovasc Imaging 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Positive effect of dapagliflozin on left ventricular longitudinal function for type 2 diabetic mellitus patients with chronic heart failure.
Hidekazu Tanaka, Fumitaka Soga, Kazuhiro Tatsumi, Yasuhide Mochizuki, Hiroyuki Sano, Hiromi Toki, Kensuke Matsumoto, Junya Shite, Hideyuki Takaoka, Tomofumi Doi,[...]. Cardiovasc Diabetol 2020
17
50

Endothelial function and dysfunction: Impact of sodium-glucose cotransporter 2 inhibitors.
Azizah Ugusman, Jaya Kumar, Amilia Aminuddin. Pharmacol Ther 2021
1
100

Canagliflozin for Japanese patients with chronic heart failure and type II diabetes.
Akira Sezai, Hisakuni Sekino, Satoshi Unosawa, Makoto Taoka, Shunji Osaka, Masashi Tanaka. Cardiovasc Diabetol 2019
17
50

Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes.
Vaia Lambadiari, George Pavlidis, Foteini Kousathana, Maria Varoudi, Dimitrios Vlastos, Eirini Maratou, Dimitrios Georgiou, Ioanna Andreadou, John Parissis, Helen Triantafyllidi,[...]. Cardiovasc Diabetol 2018
53
50

Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure.
Fumitaka Soga, Hidekazu Tanaka, Kazuhiro Tatsumi, Yasuhide Mochizuki, Hiroyuki Sano, Hiromi Toki, Kensuke Matsumoto, Junya Shite, Hideyuki Takaoka, Tomofumi Doi,[...]. Cardiovasc Diabetol 2018
72
50

Effects of oral antidiabetic drugs and glucagon-like peptide-1 receptor agonists on left ventricular diastolic function in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis.
Satoshi Ida, Ryutaro Kaneko, Kanako Imataka, Kaoru Okubo, Yoshitaka Shirakura, Kentaro Azuma, Ryoko Fujiwara, Hiroka Takahashi, Kazuya Murata. Heart Fail Rev 2021
1
100

Comparison of New Glucose-Lowering Drugs on Risk of Heart Failure in Type 2 Diabetes: A Network Meta-Analysis.
Caroline K Kramer, Chang Ye, Sara Campbell, Ravi Retnakaran. JACC Heart Fail 2018
20
50

Exenatide improves diastolic function and attenuates arterial stiffness but does not alter exercise capacity in individuals with type 2 diabetes.
Rebecca L Scalzo, Kerrie L Moreau, Cemal Ozemek, Leah Herlache, Shawna McMillin, Sarah Gilligan, Amy G Huebschmann, Tim A Bauer, Jennifer Dorosz, Jane E B Reusch,[...]. J Diabetes Complications 2017
30
50

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
50

Effect of Empagliflozin on Left Ventricular Mass and Diastolic Function in Individuals With Diabetes: An Important Clue to the EMPA-REG OUTCOME Trial?
Subodh Verma, Ankit Garg, Andrew T Yan, Anup K Gupta, Mohammed Al-Omran, Andre Sabongui, Hwee Teoh, C David Mazer, Kim A Connelly. Diabetes Care 2016
107
50

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Søren L Kristensen, Rasmus Rørth, Pardeep S Jhund, Kieran F Docherty, Naveed Sattar, David Preiss, Lars Køber, Mark C Petrie, John J V McMurray. Lancet Diabetes Endocrinol 2019
319
50

Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA-HFpEF trial.
Mariëlle Scheffer, Annet Driessen-Waaijer, Nazha Hamdani, Jochem W D Landzaat, Nini H Jonkman, Walter J Paulus, Loek van Heerebeek. ESC Heart Fail 2020
5
50

The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction.
Coenraad Withaar, Laura M G Meems, George Markousis-Mavrogenis, Cornelis J Boogerd, Herman H W Silljé, Elisabeth M Schouten, Martin M Dokter, Adriaan A Voors, B Daan Westenbrink, Carolyn S P Lam,[...]. Cardiovasc Res 2021
11
50

Effects of antidiabetic drugs on left ventricular function/dysfunction: a systematic review and network meta-analysis.
Da-Peng Zhang, Li Xu, Le-Feng Wang, Hong-Jiang Wang, Feng Jiang. Cardiovasc Diabetol 2020
13
50


Dapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.
Eirini Papadopoulou, Charalampos Loutradis, Glykeria Tzatzagou, Kalliopi Kotsa, Ioanna Zografou, Ioanna Minopoulou, Marietta P Theodorakopoulou, Apostolos Tsapas, Asterios Karagiannis, Pantelis Sarafidis. J Hypertens 2021
7
50

Effect of dapagliflozin on cardiac function in people with type 2 diabetes and albuminuria - A double blind randomized placebo-controlled crossover trial.
Mie K Eickhoff, Flemming J Olsen, Marie Frimodt-Møller, Lars J Diaz, Jens Faber, Magnus T Jensen, Peter Rossing, Frederik Persson. J Diabetes Complications 2020
2
50

Heart failure and renal outcomes according to baseline and achieved blood pressure in patients with type 2 diabetes: results from EMPA-REG OUTCOME.
Michael Böhm, David Fitchett, Anne Pernille Ofstad, Martina Brueckmann, Stefan Kaspers, Jyothis T George, Isabella Zwiener, Bernard Zinman, Christoph Wanner, Nikolaus Marx,[...]. J Hypertens 2020
5
50

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
50

Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2.
Vance B Matthews, Rosemary H Elliot, Caroline Rudnicka, Jana Hricova, Lakshini Herat, Markus P Schlaich. J Hypertens 2017
73
50


Effects of liraglutide on diastolic function parameters in patients with type 2 diabetes and coronary artery disease: a randomized crossover study.
Preman Kumarathurai, Ahmad Sajadieh, Christian Anholm, Ole P Kristiansen, Steen B Haugaard, Olav W Nielsen. Cardiovasc Diabetol 2021
3
50

Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials.
Yao Hao Teo, Yao Neng Teo, Nicholas L Syn, Cheryl Shumin Kow, Celine Shuen Yin Yoong, Benjamin Y Q Tan, Tiong-Cheng Yeo, Chi-Hang Lee, Weiqin Lin, Ching-Hui Sia. J Am Heart Assoc 2021
4
50


Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies.
Ling Li, Sheyu Li, Ke Deng, Jiali Liu, Per Olav Vandvik, Pujing Zhao, Longhao Zhang, Jiantong Shen, Malgorzata M Bala, Zahra N Sohani,[...]. BMJ 2016
136
50


GLP-1 Improves Diastolic Function and Survival in Heart Failure with Preserved Ejection Fraction.
T Dung Nguyen, Yasushige Shingu, Paulo A Amorim, Christina Schenkl, Michael Schwarzer, Torsten Doenst. J Cardiovasc Transl Res 2018
10
50

Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.
Anders Jorsal, Caroline Kistorp, Pernille Holmager, Rasmus Stilling Tougaard, Roni Nielsen, Anja Hänselmann, Brian Nilsson, Jacob Eifer Møller, Jakob Hjort, Jon Rasmussen,[...]. Eur J Heart Fail 2017
178
50

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer,[...]. N Engl J Med 2013
50

The effects of dipeptidyl peptidase-4 on cardiac fibrosis in pressure overload-induced heart failure.
Masanori Hirose, Hiroyuki Takano, Hiroshi Hasegawa, Hiroyuki Tadokoro, Naoko Hashimoto, Genzo Takemura, Yoshio Kobayashi. J Pharmacol Sci 2017
9
50


Different effects of SGLT2 inhibitors according to the presence and types of heart failure in type 2 diabetic patients.
In-Chang Hwang, Goo-Yeong Cho, Yeonyee E Yoon, Jin Joo Park, Jun-Bean Park, Seung-Pyo Lee, Hyung-Kwan Kim, Yong-Jin Kim, Dae-Won Sohn. Cardiovasc Diabetol 2020
7
50


2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee.
Thomas M Maddox, James L Januzzi, Larry A Allen, Khadijah Breathett, Javed Butler, Leslie L Davis, Gregg C Fonarow, Nasrien E Ibrahim, JoAnn Lindenfeld, Frederick A Masoudi,[...]. J Am Coll Cardiol 2021
38
50

Left ventricular diastolic function in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor- a pilot study.
Katia Camarano Nogueira, Meive Furtado, Rosa Tsuneshiro Fukui, Marcia Regina Silva Correia, Rosa Ferreira Dos Santos, José Lázaro Andrade, Maria Elizabeth Rossi da Silva. Diabetol Metab Syndr 2014
17
50

Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
Darren K McGuire, John H Alexander, Odd Erik Johansen, Vlado Perkovic, Julio Rosenstock, Mark E Cooper, Christoph Wanner, Steven E Kahn, Robert D Toto, Bernard Zinman,[...]. Circulation 2019
81
50

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn,[...]. N Engl J Med 2015
50

Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial.
Maurice B Bizino, Ingrid M Jazet, Jos J M Westenberg, Huub J van Eyk, Elisabeth H M Paiman, Jan W A Smit, Hildebrandus J Lamb. Cardiovasc Diabetol 2019
35
50


Liraglutide relieves cardiac dilated function than DPP-4 inhibitors.
Takeyuki Hiramatsu, Yuko Asano, Masatsuna Mabuchi, Kentaro Imai, Daiki Iguchi, Shinji Furuta. Eur J Clin Invest 2018
8
50

Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized controlled study.
Matthias Rau, Kirsten Thiele, Niels-Ulrik Korbinian Hartmann, Alexander Schuh, Ertunc Altiok, Julia Möllmann, András P Keszei, Michael Böhm, Nikolaus Marx, Michael Lehrke. Cardiovasc Diabetol 2021
4
50

Improved diastolic function in type 2 diabetes after a six month liraglutide treatment.
Fabio Saponaro, Andrea Sonaglioni, Antonio Rossi, Laura Montefusco, Michele Lombardo, Guido Adda, Maura Arosio. Diabetes Res Clin Pract 2016
19
50

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
Scott D Solomon, John J V McMurray, Inder S Anand, Junbo Ge, Carolyn S P Lam, Aldo P Maggioni, Felipe Martinez, Milton Packer, Marc A Pfeffer, Burkert Pieske,[...]. N Engl J Med 2019
460
50

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann,[...]. N Engl J Med 2020
492
50

Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Randomized Placebo-Controlled Trial.
John J V McMurray, Piotr Ponikowski, Geremia B Bolli, Valentina Lukashevich, Plamen Kozlovski, Wolfgang Kothny, James D Lewsey, Henry Krum. JACC Heart Fail 2018
66
50

Mechanisms and Evidence for Heart Failure Benefits from SGLT2 Inhibitors.
Cezary Wojcik, Bruce A Warden. Curr Cardiol Rep 2019
14
50

Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus: The IDDIA Trial.
Chi Young Shim, Jiwon Seo, Iksung Cho, Chan Joo Lee, In-Jeong Cho, Purevjargal Lhagvasuren, Seok-Min Kang, Jong-Won Ha, Gyoonhee Han, Yangsoo Jang,[...]. Circulation 2021
8
50

Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
Kenneth B Margulies, Adrian F Hernandez, Margaret M Redfield, Michael M Givertz, Guilherme H Oliveira, Robert Cole, Douglas L Mann, David J Whellan, Michael S Kiernan, G Michael Felker,[...]. JAMA 2016
266
50


Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study.
Hirotsugu Yamada, Atsushi Tanaka, Kenya Kusunose, Rie Amano, Munehide Matsuhisa, Hiroyuki Daida, Masaaki Ito, Hiroyuki Tsutsui, Mamoru Nanasato, Haruo Kamiya,[...]. Cardiovasc Diabetol 2017
28
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.